Reduced-Method Robustness Testing of Analytical Methods Driven by a Risk-Based Approach

April 2, 2010
Alice Laures

Alice Laures is an analytical chemist in analytical sciences/chemical development at GlaxoSmithKline in the UK.

,
George Okafo

George Okafo is a manager in Scinovo, Preclinical Development at GlaxoSmithKline (UK).

,
Patrick Jackson

Patrick Johnson is an analytical chemist in analytical sciences/chemical development at GlaxoSmithKline in the UK.

,
Phil Borman

Phil Borman, DSc, has served in multiple quality-related roles at GlaxoSmithKline; as of April 2021, he is senior fellow and director of product quality.

,
Marion Chatfield

Marion Chatfield is a manager in Statistical Sciences at GlaxoSmithKline (Hertfordshire).

Pharmaceutical Technology, Pharmaceutical Technology-04-02-2010, Volume 34, Issue 4

The authors describe a novel approach for assessing method robustness. This article contains online-bonus material and was copublished with Pharmaceutical Technology Europe.

Please refer to the full online version of this article, located here.